InvestorsHub Logo
Followers 0
Posts 52
Boards Moderated 0
Alias Born 04/11/2011

Re: None

Wednesday, 03/15/2017 4:34:21 PM

Wednesday, March 15, 2017 4:34:21 PM

Post# of 106837
"Today, we contend that U.S. Stem Cell is a combination of opportunistic business enterprises. We estimate that the products and services we offer through US Stem Cell Training, Vetbiologics, and US Stem Cell Clinics has the potential, although we cannot provide assurances as to if and when it will be accomplished, to drive up to $100 million dollars in cumulative peak annual revenues. What we are establishing is a foundation of value in the products and services we are selling and plan to sell from US Stem Cell Training, Vetbiologics, and US Stem Cell clinics. Our strategy is to expand the revenues generated from each of these operating divisions and to reinvest the profits we generate into our U.S. Stem Cell clinical development pipeline."

I found this very promising. Any thoughts? HH